Russian Journal of General Chemistry, Journal Year: 2024, Volume and Issue: 94(10), P. 2593 - 2602
Published: Oct. 1, 2024
Language: Английский
Russian Journal of General Chemistry, Journal Year: 2024, Volume and Issue: 94(10), P. 2593 - 2602
Published: Oct. 1, 2024
Language: Английский
Molecular Biology Reports, Journal Year: 2025, Volume and Issue: 52(1)
Published: Feb. 17, 2025
Language: Английский
Citations
1Journal of Molecular Structure, Journal Year: 2024, Volume and Issue: unknown, P. 140072 - 140072
Published: Sept. 1, 2024
Language: Английский
Citations
4ChemistrySelect, Journal Year: 2025, Volume and Issue: 10(1)
Published: Jan. 1, 2025
Abstract Recent advancements in the synthesis of aromatic heterocycles have shown promise inhibition monoamine oxidase (MAO) A and B enzymes implicated pathophysiology Parkinson's disease (PD). These heterocyclic compounds are particular interest due to their structural diversity significant pharmacological potential.This review discusses various strategies for enhancing MAO inhibitory activity, emphasizing positional modifications. Notable progress includes development thiazole‐based imidazole‐based with detailed exploration synthetic methodologies structure–activity relationships. demonstrated potential targeting metabolism neurotransmitters, particularly dopamine, which is crucial managing PD symptoms.The offers a promising pathway developing novel therapeutics disease. The these compounds, combined ability modulate neurotransmitter levels, present hopeful avenue more effective management. However, further research, including structure‐based design vivo validation, essential fully realize therapeutic efficacy improve treatment outcomes
Language: Английский
Citations
0Journal of Molecular Structure, Journal Year: 2025, Volume and Issue: unknown, P. 142015 - 142015
Published: March 1, 2025
Language: Английский
Citations
0Scientific Reports, Journal Year: 2025, Volume and Issue: 15(1)
Published: March 31, 2025
Abstract The synthesis of new quinoline-sulphonamide derivatives was accomplished through a meticulous five-step molecular assembly utilizing Suzuki, acid–amine cross-coupling reactions and N-alkylation. integrity each derivative thoroughly confirmed via comprehensive spectroscopic analyses, including 1 H 13 C NMR, DEPT-135, H- COSY, HSQC NMR HRMS techniques. Subsequently, the absorbance emission spectra newly synthesized were investigated. Absorbance determined to be restricted within range 337 nm 341.73 nm, with compound 10j exhibiting maximum wavelength nm; conversely, uniformly detected 411.70 429.90 upon excitation at 340 10f demonstrating highest nm. Notably, these fluorophores displayed impressive characteristics, high intensity significant molar extinction coefficients; quantum yield ranging from 0.015 0.558 along stokes shifts in 10h (0.6237 × 10 –4 ) acetonitrile solvent. Additionally, 10p showed strong binding affinity favorable pharmacokinetic properties docking studies ADMET calculations. electronic structure molecules elucidated using techniques such as density functional theory (DFT) electrostatic potential (MEP) mapping. calculated global reactivity parameters provided valuable insights. Compound exhibited distinctly low energy gap compared other compounds, its exceptional properties. comparison between experimental theoretical UV–vis major contribution transition percentage also showcased remarkable consistency quality derivatives, highlighting this work field fluorophore biological application.
Language: Английский
Citations
0Journal of Pharmacology and Experimental Therapeutics, Journal Year: 2025, Volume and Issue: unknown, P. 103606 - 103606
Published: May 1, 2025
Language: Английский
Citations
0Bioorganic & Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 113, P. 117926 - 117926
Published: Sept. 13, 2024
Language: Английский
Citations
3International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(12), P. 6803 - 6803
Published: June 20, 2024
Inhibitors of monoamine oxidases (MAOs) are interest for the treatment neurodegenerative disorders and other human pathologies. In this frame, present work describes different synthetic strategies to obtain MAO inhibitors via coupling aminocoumarin core with arylsulfonyl chlorides followed by copper azide-alkyne cycloaddition, leading coumarin-sulfonamide-nitroindazolyl-triazole hybrids. The nitration position on coumarin moiety was confirmed through nuclear magnetic resonance spectroscopy molecular electron density theory in order elucidate mechanism selectivity electrophilic aromatic substitution reaction. derivatives were evaluated their inhibitory potency against cholinesterases. Molecular docking calculations provided a rational binding mode best compounds series A B. identified hybrids 14a-c as novel inhibitors, selective action isoform B, potential combat neurological diseases.
Language: Английский
Citations
0Published: Jan. 1, 2024
Language: Английский
Citations
0Russian Journal of General Chemistry, Journal Year: 2024, Volume and Issue: 94(10), P. 2593 - 2602
Published: Oct. 1, 2024
Language: Английский
Citations
0